GUMDROP : JHMI J1180 An Exploratory Study to Investigate the Immunomodulatory Activity of Various Dose Levels of Anti Programmed Death 1 Antibody, BMS-936558, in Metastatic Clear Cell RCC

Created by Nancy Dawson on Apr 28, 2013
Description:The purpose of this study is to evaluate the pharmacodynamic and biologic properties of BMS-936558 in subjects with metastatic renal cell carcinoma.
Link:http://clinicaltrials.gov/ct2/show/NCT01358721
Site:Johns Hopkins University
Principal Investigator:Jenny Kim